CompletedNot Applicable

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Germany3,100 participantsStarted 2023-02-02

Plain-language summary

Vifor International Inc. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female adult patients with CKD (≥18 years) receiving HD for at least 3 months prior to signing informed consent * Signed informed consent * Able and willing to fill in questionnaires Exclusion Criteria: * Patients performing HD at home or both home and centre

What they're measuring

Prevalence of CKD-aP in HD patients

Timeframe: A 7-month study timeline

Trial details

NCT IDNCT05524467

SponsorVifor (International) Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-01-31

View on ClinicalTrials.gov More Chronic Kidney Disease-associated Pruritus trials